50.40
+2.57(+5.37%)
Currency In USD
| Previous Close | 47.83 |
| Open | 48.24 |
| Day High | 50.68 |
| Day Low | 47.87 |
| 52-Week High | 59.39 |
| 52-Week Low | 29.31 |
| Volume | 2.1M |
| Average Volume | 2.06M |
| Market Cap | 6.03B |
| PE | -9.84 |
| EPS | -5.12 |
| Moving Average 50 Days | 41.86 |
| Moving Average 200 Days | 41.09 |
| Change | 2.57 |
If you invested $1000 in Cytokinetics, Incorporated (CYTK) 10 years ago, it would be worth $7,789.8 as of September 29, 2025 at a share price of $50.4. Whereas If you bought $1000 worth of Cytokinetics, Incorporated (CYTK) shares 5 years ago, it would be worth $2,257.05 as of September 29, 2025 at a share price of $50.4.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cytokinetics Announces Call for Proposals for Its Eighth Annual Communications Grant Program
GlobeNewswire Inc.
Sep 24, 2025 11:30 AM GMT
Program to Provide Support of Communications and Outreach for Patient Advocacy Organizations Focused on Cardiovascular Diseases Deadline for Applications is November 3rd, 2025 SOUTH SAN FRANCISCO, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Cytokine
Cytokinetics to Present at the Stifel 2025 Virtual Cardiometabolic Forum
GlobeNewswire Inc.
Sep 23, 2025 8:00 PM GMT
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company’s management team are scheduled to present a corporate update at the Stifel 2025 Virtual Cardiomet
Cytokinetics Announces Three Upcoming Presentations at the HFSA Annual Scientific Meeting 2025
GlobeNewswire Inc.
Sep 18, 2025 11:30 AM GMT
Long-Term Data from FOREST-HCM in Non-Obstructive HCM and Results from Prespecified Analysis of MAPLE-HCM to be Presented in Late-Breaking Clinical Research Session SOUTH SAN FRANCISCO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inco